MODAFINIL | A207196 | APPCO PHARMA LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Appco Pharma LLC FDA-2026-P-8559 · 10 docket documents Appco Pharma LLC filed a suitability petition regarding the regulatory pathway and approvability of a drug product, seeking FDA guidance on whether the proposed formulation and manufacturing process meet the agency's standards for approval under applicable regulatory mechanisms such as ANDA or NDA s | Suitability | 2026-08-04 | Open | Appco Pharma LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.3483
per ea
Lowest NADAC/Unit
$0.2420
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 23155060503MODAFINIL 200 MG TABLET | $0.3483 | EA | Generic | — | 2026-08-19 |
| 23155060509MODAFINIL 200 MG TABLET | $0.3483 | EA | Generic | — | 2026-08-19 |
| 23155086203MODAFINIL 200 MG TABLET | $0.3483 | EA | Generic | — | 2026-08-19 |
| 23155086209MODAFINIL 200 MG TABLET | $0.3483 | EA | Generic | — | 2026-08-19 |
| 23155060403MODAFINIL 100 MG TABLET | $0.2420 | EA | Generic | — | 2026-08-19 |
| 23155060409MODAFINIL 100 MG TABLET | $0.2420 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.